• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 15, 2023

    3/15/23 9:41:03 AM ET
    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Computer Software: Prepackaged Software
    Technology
    Major Chemicals
    Industrials
    Get the next $ADBE alert in real time by email

    Companies Reporting Before The Bell

    • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.

    • InfuSystems Holdings (AMEX:INFU) is projected to report quarterly earnings at $0.04 per share on revenue of $30.80 million.

    • Kandi Technologies Gr (NASDAQ:KNDI) is projected to report quarterly earnings at $0.02 per share on revenue of $49.30 million.

    • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.34 per share on revenue of $341.25 million.

    • Calumet Specialty (NASDAQ:CLMT) is likely to report quarterly earnings at $0.00 per share on revenue of $904.43 million.

    • Oatly Group (NASDAQ:OTLY) is likely to report quarterly loss at $0.14 per share on revenue of $181.52 million.

    • Ebix (NASDAQ:EBIX) is estimated to report quarterly earnings at $0.54 per share on revenue of $251.04 million.

    • Ucloudlink Group (NASDAQ:UCL) is projected to report quarterly loss at $0.08 per share on revenue of $20.20 million.

    • Kamada (NASDAQ:KMDA) is estimated to report quarterly earnings at $0.06 per share on revenue of $44.64 million.

    • Star Equity Hldgs (NASDAQ:STRR) is projected to report quarterly loss at $0.02 per share on revenue of $28.75 million.

    • Waldencast (NASDAQ:WALD) is likely to report quarterly loss at $0.01 per share on revenue of $51.55 million.

    • HOOKIPA Pharma (NASDAQ:HOOK) is likely to report quarterly loss at $0.21 per share on revenue of $7.07 million.

    • Ranpak Hldgs (NYSE:PACK) is likely to report quarterly loss at $0.09 per share on revenue of $90.48 million.

    • Circor Intl (NYSE:CIR) is likely to report quarterly earnings at $0.39 per share on revenue of $204.00 million.

    • Charge Enterprises (NASDAQ:CRGE) is likely to report quarterly loss at $0.05 per share on revenue of $190.32 million.

    • Arcos Dorados Holdings (NYSE:ARCO) is projected to report quarterly earnings at $0.23 per share on revenue of $990.25 million.

    • Silence Therapeutics (NASDAQ:SLN) is estimated to report earnings for its fourth quarter.

    • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.05 per share on revenue of $229.72 million.

    • BRC (NYSE:BRCC) is projected to report quarterly loss at $0.07 per share on revenue of $92.39 million.

    • BrainsWay (NASDAQ:BWAY) is estimated to report quarterly loss at $0.13 per share on revenue of $6.20 million.

    • Enlight Renewable Energy (NASDAQ:ENLT) is estimated to report earnings for its fourth quarter.

    • KNOT Offshore Partners (NYSE:KNOP) is likely to report quarterly earnings at $0.17 per share on revenue of $69.03 million.

    • Chindata Group Holdings (NASDAQ:CD) is projected to report earnings for its fourth quarter.

    • Audacy (NYSE:AUD) is estimated to report quarterly earnings at $0.07 per share on revenue of $344.12 million.

    Companies Reporting After The Bell

    • RCM Technologies (NASDAQ:RCMT) is projected to report quarterly earnings at $0.47 per share on revenue of $68.88 million.

    • Sigilon Therapeutics (NASDAQ:SGTX) is likely to report quarterly loss at $0.38 per share on revenue of $2.67 million.

    • Zedge (AMEX:ZDGE) is projected to report quarterly loss at $0.11 per share on revenue of $7.03 million.

    • IMV (NASDAQ:IMV) is estimated to report quarterly loss at $1.64 per share on revenue of $40 thousand.

    • Proterra (NASDAQ:PTRA) is likely to report quarterly loss at $0.25 per share on revenue of $86.85 million.

    • LivePerson (NASDAQ:LPSN) is likely to report quarterly loss at $0.35 per share on revenue of $126.96 million.

    • Liminal Biosciences (NASDAQ:LMNL) is projected to report earnings for its fourth quarter.

    • Champions Oncology (NASDAQ:CSBR) is projected to report quarterly loss at $0.03 per share on revenue of $13.13 million.

    • Senseonics Holdings (AMEX:SENS) is expected to report earnings for its fourth quarter.

    • VolitionRX (AMEX:VNRX) is projected to report quarterly loss at $0.15 per share on revenue of $220 thousand.

    • Legacy Housing (NASDAQ:LEGH) is projected to report quarterly earnings at $0.60 per share on revenue of $60.63 million.

    • JOYY (NASDAQ:YY) is projected to report quarterly earnings at $0.24 per share on revenue of $599.90 million.

    • Groupon (NASDAQ:GRPN) is estimated to report quarterly loss at $0.40 per share on revenue of $161.55 million.

    • Franco-Nevada (NYSE:FNV) is expected to report quarterly earnings at $1.15 per share on revenue of $419.59 million.

    • UiPath (NYSE:PATH) is projected to report quarterly earnings at $0.06 per share on revenue of $278.62 million.

    • Owlet (NYSE:OWLT) is expected to report quarterly loss at $0.15 per share on revenue of $12.92 million.

    • Array Technologies (NASDAQ:ARRY) is expected to report quarterly earnings at $0.08 per share on revenue of $366.77 million.

    • Catalyst Pharmaceuticals (NASDAQ:CPRX) is expected to report quarterly earnings at $0.21 per share on revenue of $58.09 million.

    • Tutor Perini (NYSE:TPC) is estimated to report quarterly earnings at $0.01 per share on revenue of $976.17 million.

    • Matinas BioPharma Hldgs (AMEX:MTNB) is projected to report quarterly loss at $0.03 per share on revenue of $1.07 million.

    • MorphoSys (NASDAQ:MOR) is projected to report quarterly loss at $0.44 per share on revenue of $80.01 million.

    • FG Group Holdings (AMEX:FGH) is expected to report earnings for its fourth quarter.

    • Vaxart (NASDAQ:VXRT) is likely to report quarterly loss at $0.23 per share on revenue of $670 thousand.

    • AEye (NASDAQ:LIDR) is projected to report quarterly loss at $0.15 per share on revenue of $1.02 million.

    • SuRo Capital (NASDAQ:SSSS) is estimated to report earnings for its fourth quarter.

    • Inspirato (NASDAQ:ISPO) is projected to report quarterly loss at $0.15 per share on revenue of $80.77 million.

    • Capricor Therapeutics (NASDAQ:CAPR) is estimated to report earnings for its fourth quarter.

    • Zomedica (AMEX:ZOM) is expected to report earnings for its fourth quarter.

    • Cyngn (NASDAQ:CYN) is estimated to report earnings for its fourth quarter.

    • Macrogenics (NASDAQ:MGNX) is estimated to report earnings for its fourth quarter.

    • Park-Ohio Hldgs (NASDAQ:PKOH) is expected to report quarterly earnings at $0.46 per share on revenue of $427.10 million.

    • Pangaea Logistics Solns (NASDAQ:PANL) is projected to report quarterly earnings at $0.29 per share on revenue of $157.20 million.

    • Superior Gr of Cos (NASDAQ:SGC) is expected to report quarterly earnings at $0.07 per share on revenue of $143.70 million.

    • Hesai Gr (NASDAQ:HSAI) is projected to report earnings for its first quarter.

    • Brilliant Earth Group (NASDAQ:BRLT) is expected to report quarterly earnings at $0.05 per share on revenue of $123.39 million.

    • Mineralys Therapeutics (NASDAQ:MLYS) is estimated to report earnings for its fourth quarter.

    • ToughBuilt Industries (NASDAQ:TBLT) is expected to report earnings for its fourth quarter.

    • IDW Media Holdings (AMEX:IDW) is projected to report earnings for its first quarter.

    • Fluent (NASDAQ:FLNT) is projected to report quarterly loss at $0.01 per share on revenue of $89.27 million.

    • CTS (NYSE:CTS) is likely to report quarterly earnings at $0.10 per share on revenue of $774.58 million.

    • Avinger (NASDAQ:AVGR) is likely to report earnings for its fourth quarter.

    • Fortuna Silver Mines (NYSE:FSM) is likely to report earnings for its fourth quarter.

    • Cue Health (NASDAQ:HLTH) is likely to report quarterly loss at $0.45 per share on revenue of $47.77 million.

    • Five Below (NASDAQ:FIVE) is estimated to report quarterly earnings at $3.06 per share on revenue of $1.11 billion.

    • Natures Sunshine Products (NASDAQ:NATR) is expected to report quarterly loss at $0.04 per share on revenue of $100.26 million.

    • Ontrak (NASDAQ:OTRK) is estimated to report quarterly loss at $0.55 per share on revenue of $3.00 million.

    • Northwest Pipe (NASDAQ:NWPX) is likely to report quarterly earnings at $0.71 per share on revenue of $109.35 million.

    • Cadre Hldgs (NYSE:CDRE) is expected to report quarterly earnings at $0.21 per share on revenue of $115.70 million.

    • ZTO Express (Cayman) (NYSE:ZTO) is projected to report quarterly earnings at $0.37 per share on revenue of $1.47 billion.

    • Ideanomics (NASDAQ:IDEX) is estimated to report quarterly loss at $0.08 per share on revenue of $48.80 million.

    • Boxlight (NASDAQ:BOXL) is estimated to report quarterly loss at $0.05 per share on revenue of $48.06 million.

    • EverCommerce (NASDAQ:EVCM) is projected to report quarterly earnings at $0.08 per share on revenue of $157.97 million.

    • MaxCyte (NASDAQ:MXCT) is likely to report quarterly loss at $0.07 per share on revenue of $12.90 million.

    • Adobe (NASDAQ:ADBE) is expected to report quarterly earnings at $3.68 per share on revenue of $4.62 billion.

    • Alpha Teknova (NASDAQ:TKNO) is projected to report quarterly loss at $0.34 per share on revenue of $7.72 million.

    • Amyris (NASDAQ:AMRS) is expected to report quarterly loss at $0.27 per share on revenue of $104.10 million.

    • GrowGeneration (NASDAQ:GRWG) is likely to report quarterly loss at $0.11 per share on revenue of $51.78 million.

    • NACCO Industries (NYSE:NC) is estimated to report earnings for its fourth quarter.

    • PagerDuty (NYSE:PD) is expected to report quarterly earnings at $0.02 per share on revenue of $98.84 million.

    • NuScale Power (NYSE:SMR) is projected to report quarterly loss at $0.02 per share on revenue of $5.00 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $AMRS
    $ARCO
    $ARRY

    CompanyDatePrice TargetRatingAnalyst
    NuScale Power Corporation
    $SMR
    2/11/2026Buy → Hold
    TD Cowen
    Hesai Group
    $HSAI
    2/10/2026$31.50Outperform
    Macquarie
    ZTO Express (Cayman) Inc.
    $ZTO
    2/9/2026$26.60Neutral → Outperform
    Macquarie
    Park-Ohio Holdings Corp.
    $PKOH
    2/9/2026$37.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Five Below Inc.
    $FIVE
    2/4/2026$233.00Underperform → Buy
    BofA Securities
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Array Technologies Inc.
    $ARRY
    1/28/2026$11.00Outperform → Neutral
    Robert W. Baird
    Babcock & Wilcox Enterprises Inc.
    $BW
    1/22/2026$10.00Outperform
    Northland Capital
    More analyst ratings

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA

    Submission status for MACROGENICS INC's drug MARGENZA (ORIG-1) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 12/16/2020. Application Category: BLA, Application Number: 761150, Application Classification:

    12/20/20 4:31:01 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Rodman David Malcom exercised 2,171 shares at a strike of $16.00 and sold $65,586 worth of shares (2,171 units at $30.21) (SEC Form 4)

    4 - Mineralys Therapeutics, Inc. (0001933414) (Issuer)

    2/11/26 6:58:56 PM ET
    $MLYS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Senior Vice President Trivedi Pratik covered exercise/tax liability with 125 shares, decreasing direct ownership by 2% to 7,938 units (SEC Form 4)

    4/A - CTS CORP (0000026058) (Issuer)

    2/11/26 4:30:00 PM ET
    $CTS
    Electrical Products
    Technology

    President & CEO O'Sullivan Kieran M covered exercise/tax liability with 6,980 shares, decreasing direct ownership by 2% to 403,750 units (SEC Form 4)

    4 - CTS CORP (0000026058) (Issuer)

    2/11/26 4:29:13 PM ET
    $CTS
    Electrical Products
    Technology

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    SEC Filings

    View All

    SEC Form DEF 14A filed by VolitionRX Limited

    DEF 14A - VOLITIONRX LTD (0000093314) (Filer)

    2/11/26 5:05:44 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 6-K filed by Oatly Group AB

    6-K - Oatly Group AB (0001843586) (Filer)

    2/11/26 4:07:50 PM ET
    $OTLY
    Packaged Foods
    Consumer Staples

    AEye Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AEye, Inc. (0001818644) (Filer)

    2/11/26 4:05:35 PM ET
    $LIDR
    Auto Parts:O.E.M.
    Consumer Discretionary

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NuScale Power downgraded by TD Cowen

    TD Cowen downgraded NuScale Power from Buy to Hold

    2/11/26 7:50:27 AM ET
    $SMR
    Metal Fabrications
    Industrials

    Macquarie initiated coverage on Hesai Group with a new price target

    Macquarie initiated coverage of Hesai Group with a rating of Outperform and set a new price target of $31.50

    2/10/26 9:51:02 AM ET
    $HSAI
    Industrial Machinery/Components
    Industrials

    ZTO Express upgraded by Macquarie with a new price target

    Macquarie upgraded ZTO Express from Neutral to Outperform and set a new price target of $26.60

    2/9/26 6:59:30 AM ET
    $ZTO
    Trucking Freight/Courier Services
    Industrials

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Eberwein Jeffrey E. sold $39,794 worth of Series A Preferred Stock (4,365 units at $9.12) and bought $81,503 worth of shares (7,268 units at $11.21), increasing direct ownership by 27% to 1,007,824 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/31/25 5:02:24 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. sold $173,974 worth of Series A Preferred Stock (18,635 units at $9.34) and bought $109,212 worth of shares (9,709 units at $11.25), increasing direct ownership by 23% to 1,000,556 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/29/25 7:09:34 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    Chief Executive Officer Eberwein Jeffrey E. bought $2,999,991 worth of shares (287,631 units at $10.43) and sold $2,999,994 worth of Series A Preferred Stock (320,855 units at $9.35), increasing direct ownership by 15% to 810,217 units (SEC Form 4)

    4 - Star Equity Holdings, Inc. (0001210708) (Issuer)

    12/10/25 4:01:17 PM ET
    $STRR
    Professional Services
    Consumer Discretionary

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

    RADNOR, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ:MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that on February 9, 2026, the Compensation Committee of Mineralys' Board of Directors granted inducement stock option awards covering 33,504 shares and inducement restricted stock unit awards covering 25,128 shares of Mineralys common stock to two new non-executive employees. The awards were granted under Mineralys' 2025 Employment Inducemen

    2/11/26 7:00:40 PM ET
    $MLYS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UiPath Announces Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call

    UiPath, Inc. (NYSE:PATH), a global leader in agentic automation, today announced it will report financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026 after the market closes on Wednesday, March 11, 2026. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET. UiPath Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call When: Wednesday, March 11, 2026 Time: 5:00 pm ET Conference ID: 13758276 Live Call: 1-877-407-8309 (US/Canada Toll-Free) or 1-201-689-8057 (Toll) Replay: A webcast replay of the conference call will be available on the investor relations website for one year. Webcas

    2/11/26 4:10:00 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    NWPX Infrastructure to Release Fourth Quarter and Full Year 2025 Financial Results on February 25th

    Financial results to be released after market close on February 25, 2026Conference call to begin at 7:00 a.m. PT on February 26, 2026VANCOUVER, Wash., Feb. 11, 2026 /PRNewswire/ -- NWPX Infrastructure, Inc. (NASDAQ:NWPX) ("NWPX Infrastructure" and the "Company"), a leading manufacturer of water-related infrastructure products, announced today that it intends to release its financial results for the fourth quarter and full year ended December 31, 2025, on Wednesday, February 25, 2026. Scott Montross, NWPX Infrastructure's President and Chief Executive Officer, and Aaron Wilkins

    2/11/26 4:05:00 PM ET
    $NWPX
    Steel/Iron Ore
    Industrials

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Leadership Updates

    Live Leadership Updates

    View All

    Volition Announces the Appointment of New Distributor for Nu.Q® Discover

    HENDERSON, Nev., Feb. 10, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announces the appointment of Medical & Biological Laboratories Co. Ltd (MBL) as a non-exclusive distributor of its Nu.Q® Discover assays in Japan. Dr Jasmine Kway, Chief Executive Officer, Singapore Volition commented: "We are delighted to be working with MBL, a leading provider of clinical research tools in Japan, with a particular focus and track record in autoimmune diseases. "Through our Nu.Q® Discover pillar, we are now serving close to 100 clients worldwide, including many top pharma and diagnostic companies, accelerating disease research and drug developme

    2/10/26 8:07:00 AM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Babcock & Wilcox Enterprises, Inc. Appoints Dr. Homaira Akbari (Ph.D.) to Board of Directors

    Babcock & Wilcox Enterprises, Inc. (B&W) (NYSE:BW) announced today that Dr. Homaira Akbari (Ph.D.) has been appointed to its Board of Directors, bringing the total to seven members. Dr. Akbari has served on the Board of Directors of over 25 public and private companies, including Veolia Group, a global leader in waste to energy, environmentals and hazardous waste facilities, and Banco Santander (NYSE:SAN). Dr. Akbari brings extensive international leadership experience across medium and large technology companies, including in the energy and finance sectors. She has held senior management roles in Fortune 1000 companies including Microsoft, Thales and Liberty Media, and served as member

    1/27/26 4:30:00 PM ET
    $BW
    $SAN
    Building Products
    Industrials
    Commercial Banks
    Finance

    PagerDuty Appoints Scott Aronson to Board of Directors

    Former Cloudera COO and VMware Executive Brings Deep Enterprise Operations Expertise as PagerDuty Scales Global Growth PagerDuty, Inc. (NYSE:PD), a global leader in digital operations management, announced today the appointment of Scott Aronson to the company's Board of Directors, with an effective date of February 9, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120046276/en/PagerDuty Appoints Scott Aronson to Board of Directors "Scott brings exceptional enterprise, go-to-market and operations leadership experience at a pivotal time for PagerDuty," said Jennifer Tejada, Chairperson and CEO at PagerDuty. "His proven

    1/20/26 4:05:00 PM ET
    $PD
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Financials

    Live finance-specific insights

    View All

    UiPath Announces Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call

    UiPath, Inc. (NYSE:PATH), a global leader in agentic automation, today announced it will report financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026 after the market closes on Wednesday, March 11, 2026. Management will host a conference call and webcast to discuss the Company's financial results at 5:00 pm ET. UiPath Fourth Quarter and Full Year Fiscal 2026 Financial Results Conference Call When: Wednesday, March 11, 2026 Time: 5:00 pm ET Conference ID: 13758276 Live Call: 1-877-407-8309 (US/Canada Toll-Free) or 1-201-689-8057 (Toll) Replay: A webcast replay of the conference call will be available on the investor relations website for one year. Webcas

    2/11/26 4:10:00 PM ET
    $PATH
    Computer Software: Prepackaged Software
    Technology

    NWPX Infrastructure to Release Fourth Quarter and Full Year 2025 Financial Results on February 25th

    Financial results to be released after market close on February 25, 2026Conference call to begin at 7:00 a.m. PT on February 26, 2026VANCOUVER, Wash., Feb. 11, 2026 /PRNewswire/ -- NWPX Infrastructure, Inc. (NASDAQ:NWPX) ("NWPX Infrastructure" and the "Company"), a leading manufacturer of water-related infrastructure products, announced today that it intends to release its financial results for the fourth quarter and full year ended December 31, 2025, on Wednesday, February 25, 2026. Scott Montross, NWPX Infrastructure's President and Chief Executive Officer, and Aaron Wilkins

    2/11/26 4:05:00 PM ET
    $NWPX
    Steel/Iron Ore
    Industrials

    Brilliant Earth to Report Fourth Quarter and Full Year 2025 Financial Results on March 5th

    SAN FRANCISCO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. ("Brilliant Earth" or the "Company") (NASDAQ:BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that it will report fourth quarter and full year 2025 earnings results before the market opens on Thursday, March 5, 2026. The Company will host an investor conference call and webcast to review these financial results and business outlook at 8:30am ET/5:30am PT on the same day. The webcast can be accessed at https://investors.brilliantearth.com. The conference call can be accessed by using the following link: Brilliant Earth's 4Q25 Earnings Call. After registering, an email will be

    2/11/26 4:05:00 PM ET
    $BRLT
    Consumer Specialties
    Consumer Discretionary

    $ADBE
    $AMRS
    $ARCO
    $ARRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:53:36 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:59 PM ET
    $NC
    Coal Mining
    Energy

    Amendment: SEC Form SC 13D/A filed by NACCO Industries Inc.

    SC 13D/A - NACCO INDUSTRIES INC (0000789933) (Subject)

    12/17/24 3:38:47 PM ET
    $NC
    Coal Mining
    Energy